Chronic pain is a serious and costly public health issue in the United States and remains largely undertreated. Pain management requires an understanding of how chronic pain manifests and the treatment options that are available to health care practitioners. The standard of care in treating chronic pain includes the judicious use of opioids and necessitates the development of realistic strategies to prevent their misuse. Pharmacists can play an important role in improving patient outcomes by collaborating with prescribers and patients to ensure that pharmacologic treatment is optimized and that patients receive education on the proper use of opioid analgesics.
Prevalence and Economic Implications of Chronic Pain
Treatment Options for Chronic Pain Management: Opioids Revisited
Disease Management Tools for Chronic Pain
Case Studies: Managing Debilitating Chronic Pain
This supplement is based on a satellite symposium held at the Academy of Managed Care Pharmacy 2006 Education Conference in Chicago. The authors, who are considered leaders in the field of pain management, present thought-provoking articles on the optimal management of patients with chronic pain and the necessity to address this costly and highly prevalent disorder.
Managed Care Best Practices in Oncology Management
Cancer, in its various types and presentations, is the number 2 killer in the United States. For managed care companies, access to and availability of cancer care itself and the attendant costs of such care will present an increasingly substantial managed challenge. This publication serves as an important educational tool for managed care professionals, pharmacists, and other health care decision makers so that informed decisions can be made regarding drugs, devices, and procedures utilized when treating patients with cancer.
Issues in Oncology Management
The Current Landscape of Oncology in Managed Care
The Process of Care
Protocols and Working With Oncologists
Pharmacy and Cancer Care
Managing Oncology Agents: An HMO’s Perspective
Based on an expert roundtable discussion conducted in Salt Lake City, Utah, this supplement focuses on collaboration and communication as key principles for ensuring the highest quality of patient care. Case studies that discuss typical patients encountered in the oncology field are also presented.
Clinical Brief: The Unique Burden of Menstrual Migraine
Based on a breakfast symposium at the Academy of Managed Care Pharmacy 2007 Annual meeting, this supplement reviews opportunities to optimize short-term prevention of migraines in patients with specific treatment needs. The authors examine the advances in migraine prophylaxis and the emerging models in preventive treatment.
Prevalence and Burden of Migraine and The Impact on Managed Care
The Epidemiology and Pathophysiology of Migraine
Treatment of Menstrual Migraine: Evidence-Based Review
Panel Discussion: Optimal Patient Management
Influenza Vaccination: Trends, Recommendations, and Best Practices
Historically, health care professionals have focused on preventing influenza morbidity and mortality with vaccine, chiefly in the elderly and high-risk populations. Today, the larger public health objective is to prevent epidemics via complementary immunization strategies, which can include herd protection through vaccination of people who spread viruses to those at highest risk of complications and poor outcomes. New immunization strategies include vaccinating healthy children, adults, and health care workers. Efficacy data are presented for of trivalent inactivated influenza vaccine (TIV) and live attenuated influenza vaccine (LAIV), administered by nasal spray.
Burden of Influenza and Strategies for Prevention
Influenza Virus Mutation and Transmission
Best Practice From a Health Plan Standpoint
Real-World Experience of a Family Practitioner
Virginia’s Stay on Track Daycare Initiative
Panel Discussion: Overcoming Barriers to Immunization
This supplement is based on the Influenza Vaccine Expert Roundtable, held in Chicago on April 19, 2007. The authors include Robert Belshe, MD, considered a leader in the field of influenza prevention.
Conversations on The Changing Face Of Managed Care: Insights from the 2006-2007 Podcast Series
Based on a series of 10 podcasts conducted in late 2006 and early 2007 by internationally known author, consultant, and futurist Ian Morrison, this publication features interviews with various experts on issues important to the business and bottom line of managed care organizations.
Seeing Through Transparency: The Managed Care Evolution
A Health Plan Perspective – Margaret E. O’Kane
An Employer’s Perspective – Peter V. Lee, JD
A Consumer’s Perspective – Mark D. Smith, MD, MBA
Pay For Performance – Tom R. Williams
Electronic Health Information – David Brailer, MD, PhD
The Future of Disease Management – David Nash, MD, MBA
Medicare Part D – John Gorman
Evidence-Based Benefit Design – Helen Darling
Consumer-Directed Health Plans – Sara R. Collins, PhD
Specialty Pharmacy Management – Debbie Stern, RPh
Postherpetic Neuralgia: A Model for Treating Severe Pain
Postherpetic neuralgia is a disabling condition that impairs quality of life. Varying definitions of PHN have made it difficult to quantify its prevalence or qualify its severity. Clinically, PHN is a consequence of reactivation of the varicella-zoster virus. The result of viral damage to the nervous system, PHN can be severe and intractable to therapy. Targeted analgesia may be useful in reducing the chronic discomfort of PHN caused by central sensitization. Undertreatment of PHN is common and can carry costly implications for third-party payers.
Overview of Postherpetic Neuralgia (PHN)
Description of Neuropathic Pain
Clinical Manifestation of PHN
Clinical, Economic, and Quality-of-Life Burdens
Implications for Payers
Scientific Understanding of PHN and Its Treatment
Etiology of PHN
Voltage-Gated Sodium Channels
Consequences of Neuronal Damage
Targeted Peripheral Analgesics
Clinical Trials of Lidocaine Patch 5%
Clinical Brief: A Single Tablet to Help Manage Patients With Hypertension and Other Cardiovascular Risk Factors
This Brief reviews a treatment option for hypertensive patients with other cardiovascular risk factors who need the blood pressure lowering of amlodipine and the cardiovascular benefits of atorvastatin. It also includes an analysis for MCOs by Steven R. Peskin, MD, MBA.
Discussion of management of blood pressure and dyslipidemia in terms of coronary heart disease
Overview of hypertension study results, including the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid-Lowering Arm and the Collaborative Atorvastatin Diabetes Study
Clinical Brief: The Etiology of Menstrual Migraine